The global Thromboresistant Coatings market size is predicted to grow from US$ 1390 million in 2025 to US$ 2148 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

Global Thromboresistant Coatings Market Trends, Growth | CAGR %

The global Thromboresistant Coatings market size is predicted to grow from US$ 1390 million in 2025 to US$ 2148 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032. Thromboresistant coatings are specialized surface treatments applied to medical devices and implants, such as stents, catheters, and vascular grafts, to reduce the risk of blood clot formation. These coatings are designed to mimic the natural anti-thrombogenic properties of blood vessels, minimizing platelet adhesion and activation. Commonly made from biocompatible materials like heparin, hydrogels, or synthetic polymers, they enhance the safety and effectiveness of devices used in cardiovascular and other blood-contact applications. By preventing thrombosis, these coatings improve patient outcomes and extend the functionality of medical devices. United States market for Thromboresistant Coatings is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Thromboresistant Coatings is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Thromboresistant Coatings is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Thromboresistant Coatings players cover Biointeractions, Hydromer, WL Gore & Associates, Toyobo, TekCyte, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. Infinity Market Research newest research report, the Thromboresistant Coatings Industry Forecast looks at past sales and reviews total world Thromboresistant Coatings sales in 2025, providing a comprehensive analysis by region and market sector of projected Thromboresistant Coatings sales for 2026 through 2032. With Thromboresistant Coatings sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thromboresistant Coatings industry. This Insight Report provides a comprehensive analysis of the global Thromboresistant Coatings landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Thromboresistant Coatings portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Thromboresistant Coatings market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thromboresistant Coatings and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thromboresistant Coatings. This report presents a comprehensive overview, market shares, and growth opportunities of Thromboresistant Coatings market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Active Anti-thrombogenic Coating &nbsp;&nbsp;&nbsp; Inert Anti-thrombogenic Coating Segmentation by Application: &nbsp;&nbsp;&nbsp; Cardiovascular Devices &nbsp;&nbsp;&nbsp; Catheters and Cannulas &nbsp;&nbsp;&nbsp; Dialysis and Extracorporeal Circuits &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Biointeractions &nbsp;&nbsp;&nbsp; Hydromer &nbsp;&nbsp;&nbsp; WL Gore & Associates &nbsp;&nbsp;&nbsp; Toyobo &nbsp;&nbsp;&nbsp; TekCyte &nbsp;&nbsp;&nbsp; Surmodics &nbsp;&nbsp;&nbsp; Corline Biomedical &nbsp;&nbsp;&nbsp; Biomerics &nbsp;&nbsp;&nbsp; Noanix &nbsp;&nbsp;&nbsp; AST Products &nbsp;&nbsp;&nbsp; jMedtech &nbsp;&nbsp;&nbsp; Biosurf

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Thromboresistant Coatings Market Size (2021-2032) &nbsp;2.1.2 Thromboresistant Coatings Market Size CAGR by Region (2021 VS 2025 VS 2032) &nbsp;2.1.3 World Current & Future Analysis for Thromboresistant Coatings by Country/Region (2021, 2025 & 2032) &nbsp;2.2 Thromboresistant Coatings Segment by Type &nbsp;2.2.1 Active Anti-thrombogenic Coating &nbsp;2.2.2 Inert Anti-thrombogenic Coating &nbsp;2.2.3 Thromboresistant Coatings Market Size by Type &nbsp;2.2.3.1 Thromboresistant Coatings Market Size CAGR by Type (2021 VS 2025 VS 2032) &nbsp;2.2.3.2 Global Thromboresistant Coatings Market Size Market Share by Type (2021-2026) &nbsp;2.3 Thromboresistant Coatings Segment by Application &nbsp;2.3.1 Cardiovascular Devices &nbsp;2.3.2 Catheters and Cannulas &nbsp;2.3.3 Dialysis and Extracorporeal Circuits &nbsp;2.3.4 Others &nbsp;2.3.5 Thromboresistant Coatings Market Size by Application &nbsp;2.3.5.1 Thromboresistant Coatings Market Size CAGR by Application (2021 VS 2025 VS 2032) &nbsp;2.3.5.2 Global Thromboresistant Coatings Market Size Market Share by Application (2021-2026) 3 Thromboresistant Coatings Market Size by Player &nbsp;3.1 Thromboresistant Coatings Market Size Market Share by Player &nbsp;3.1.1 Global Thromboresistant Coatings Revenue by Player (2021-2026) &nbsp;3.1.2 Global Thromboresistant Coatings Revenue Market Share by Player (2021-2026) &nbsp;3.2 Global Thromboresistant Coatings Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Thromboresistant Coatings by Region &nbsp;4.1 Thromboresistant Coatings Market Size by Region (2021-2026) &nbsp;4.2 Global Thromboresistant Coatings Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Thromboresistant Coatings Market Size Growth (2021-2026) &nbsp;4.4 APAC Thromboresistant Coatings Market Size Growth (2021-2026) &nbsp;4.5 Europe Thromboresistant Coatings Market Size Growth (2021-2026) &nbsp;4.6 Middle East & Africa Thromboresistant Coatings Market Size Growth (2021-2026) 5 Americas &nbsp;5.1 Americas Thromboresistant Coatings Market Size by Country (2021-2026) &nbsp;5.2 Americas Thromboresistant Coatings Market Size by Type (2021-2026) &nbsp;5.3 Americas Thromboresistant Coatings Market Size by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Thromboresistant Coatings Market Size by Region (2021-2026) &nbsp;6.2 APAC Thromboresistant Coatings Market Size by Type (2021-2026) &nbsp;6.3 APAC Thromboresistant Coatings Market Size by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Thromboresistant Coatings Market Size by Country (2021-2026) &nbsp;7.2 Europe Thromboresistant Coatings Market Size by Type (2021-2026) &nbsp;7.3 Europe Thromboresistant Coatings Market Size by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Thromboresistant Coatings by Region (2021-2026) &nbsp;8.2 Middle East & Africa Thromboresistant Coatings Market Size by Type (2021-2026) &nbsp;8.3 Middle East & Africa Thromboresistant Coatings Market Size by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Thromboresistant Coatings Market Forecast &nbsp;10.1 Global Thromboresistant Coatings Forecast by Region (2027-2032) &nbsp;10.1.1 Global Thromboresistant Coatings Forecast by Region (2027-2032) &nbsp;10.1.2 Americas Thromboresistant Coatings Forecast &nbsp;10.1.3 APAC Thromboresistant Coatings Forecast &nbsp;10.1.4 Europe Thromboresistant Coatings Forecast &nbsp;10.1.5 Middle East & Africa Thromboresistant Coatings Forecast &nbsp;10.2 Americas Thromboresistant Coatings Forecast by Country (2027-2032) &nbsp;10.2.1 United States Market Thromboresistant Coatings Forecast &nbsp;10.2.2 Canada Market Thromboresistant Coatings Forecast &nbsp;10.2.3 Mexico Market Thromboresistant Coatings Forecast &nbsp;10.2.4 Brazil Market Thromboresistant Coatings Forecast &nbsp;10.3 APAC Thromboresistant Coatings Forecast by Region (2027-2032) &nbsp;10.3.1 China Thromboresistant Coatings Market Forecast &nbsp;10.3.2 Japan Market Thromboresistant Coatings Forecast &nbsp;10.3.3 Korea Market Thromboresistant Coatings Forecast &nbsp;10.3.4 Southeast Asia Market Thromboresistant Coatings Forecast &nbsp;10.3.5 India Market Thromboresistant Coatings Forecast &nbsp;10.3.6 Australia Market Thromboresistant Coatings Forecast &nbsp;10.4 Europe Thromboresistant Coatings Forecast by Country (2027-2032) &nbsp;10.4.1 Germany Market Thromboresistant Coatings Forecast &nbsp;10.4.2 France Market Thromboresistant Coatings Forecast &nbsp;10.4.3 UK Market Thromboresistant Coatings Forecast &nbsp;10.4.4 Italy Market Thromboresistant Coatings Forecast &nbsp;10.4.5 Russia Market Thromboresistant Coatings Forecast &nbsp;10.5 Middle East & Africa Thromboresistant Coatings Forecast by Region (2027-2032) &nbsp;10.5.1 Egypt Market Thromboresistant Coatings Forecast &nbsp;10.5.2 South Africa Market Thromboresistant Coatings Forecast &nbsp;10.5.3 Israel Market Thromboresistant Coatings Forecast &nbsp;10.5.4 Turkey Market Thromboresistant Coatings Forecast &nbsp;10.6 Global Thromboresistant Coatings Forecast by Type (2027-2032) &nbsp;10.7 Global Thromboresistant Coatings Forecast by Application (2027-2032) &nbsp;10.7.1 GCC Countries Market Thromboresistant Coatings Forecast 11 Key Players Analysis &nbsp;11.1 Biointeractions &nbsp;11.1.1 Biointeractions Company Information &nbsp;11.1.2 Biointeractions Thromboresistant Coatings Product Offered &nbsp;11.1.3 Biointeractions Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.1.4 Biointeractions Main Business Overview &nbsp;11.1.5 Biointeractions Latest Developments &nbsp;11.2 Hydromer &nbsp;11.2.1 Hydromer Company Information &nbsp;11.2.2 Hydromer Thromboresistant Coatings Product Offered &nbsp;11.2.3 Hydromer Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.2.4 Hydromer Main Business Overview &nbsp;11.2.5 Hydromer Latest Developments &nbsp;11.3 WL Gore & Associates &nbsp;11.3.1 WL Gore & Associates Company Information &nbsp;11.3.2 WL Gore & Associates Thromboresistant Coatings Product Offered &nbsp;11.3.3 WL Gore & Associates Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.3.4 WL Gore & Associates Main Business Overview &nbsp;11.3.5 WL Gore & Associates Latest Developments &nbsp;11.4 Toyobo &nbsp;11.4.1 Toyobo Company Information &nbsp;11.4.2 Toyobo Thromboresistant Coatings Product Offered &nbsp;11.4.3 Toyobo Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.4.4 Toyobo Main Business Overview &nbsp;11.4.5 Toyobo Latest Developments &nbsp;11.5 TekCyte &nbsp;11.5.1 TekCyte Company Information &nbsp;11.5.2 TekCyte Thromboresistant Coatings Product Offered &nbsp;11.5.3 TekCyte Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.5.4 TekCyte Main Business Overview &nbsp;11.5.5 TekCyte Latest Developments &nbsp;11.6 Surmodics &nbsp;11.6.1 Surmodics Company Information &nbsp;11.6.2 Surmodics Thromboresistant Coatings Product Offered &nbsp;11.6.3 Surmodics Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.6.4 Surmodics Main Business Overview &nbsp;11.6.5 Surmodics Latest Developments &nbsp;11.7 Corline Biomedical &nbsp;11.7.1 Corline Biomedical Company Information &nbsp;11.7.2 Corline Biomedical Thromboresistant Coatings Product Offered &nbsp;11.7.3 Corline Biomedical Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.7.4 Corline Biomedical Main Business Overview &nbsp;11.7.5 Corline Biomedical Latest Developments &nbsp;11.8 Biomerics &nbsp;11.8.1 Biomerics Company Information &nbsp;11.8.2 Biomerics Thromboresistant Coatings Product Offered &nbsp;11.8.3 Biomerics Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.8.4 Biomerics Main Business Overview &nbsp;11.8.5 Biomerics Latest Developments &nbsp;11.9 Noanix &nbsp;11.9.1 Noanix Company Information &nbsp;11.9.2 Noanix Thromboresistant Coatings Product Offered &nbsp;11.9.3 Noanix Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.9.4 Noanix Main Business Overview &nbsp;11.9.5 Noanix Latest Developments &nbsp;11.10 AST Products &nbsp;11.10.1 AST Products Company Information &nbsp;11.10.2 AST Products Thromboresistant Coatings Product Offered &nbsp;11.10.3 AST Products Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.10.4 AST Products Main Business Overview &nbsp;11.10.5 AST Products Latest Developments &nbsp;11.11 jMedtech &nbsp;11.11.1 jMedtech Company Information &nbsp;11.11.2 jMedtech Thromboresistant Coatings Product Offered &nbsp;11.11.3 jMedtech Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.11.4 jMedtech Main Business Overview &nbsp;11.11.5 jMedtech Latest Developments &nbsp;11.12 Biosurf &nbsp;11.12.1 Biosurf Company Information &nbsp;11.12.2 Biosurf Thromboresistant Coatings Product Offered &nbsp;11.12.3 Biosurf Thromboresistant Coatings Revenue, Gross Margin and Market Share (2021-2026) &nbsp;11.12.4 Biosurf Main Business Overview &nbsp;11.12.5 Biosurf Latest Developments 12 Research Findings and Conclusion

Report	Global Thromboresistant Coatings Market Size, Share and Opportunities 2026-2032
Selected License	Multi ID: ILR4092

Buyer Information

Order Summary